Article EMA Thank You EMA finalizes clinical anticancer therapeutic guidance update
Agency IQ
FEBRUARY 2, 2024
Predictive biomarkers enable the identification and selection of patients who are more likely to benefit from a specific treatment and would achieve a better clinical outcome in response to a specific treatment. Prognostic biomarkers enable patient selection that would have a better clinical outcome irrespective of treatment.
Let's personalize your content